These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Flecainide: a new class Ic antidysrhythmic. Smith GH Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429 [TBL] [Abstract][Full Text] [Related]
3. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Holmes B; Heel RC Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390 [TBL] [Abstract][Full Text] [Related]
4. Flecainide: a new agent for the treatment of ventricular arrhythmias. Grubb BP; Tilley-Gray B Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958 [TBL] [Abstract][Full Text] [Related]
5. Flecainide: a new prototype antiarrhythmic agent. Nappi JM; Anderson JL Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035 [TBL] [Abstract][Full Text] [Related]
6. Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Eiriksson Ce; Brogden RN Drugs; 1984 Apr; 27(4):279-300. PubMed ID: 6373222 [TBL] [Abstract][Full Text] [Related]
7. A proposal for the clinical use of flecainide. Anderson JL; Stewart JR; Crevey BJ Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767 [TBL] [Abstract][Full Text] [Related]
8. Flecainide: a new antiarrhythmic drug. Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388 [No Abstract] [Full Text] [Related]
13. The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions. Singh BN; Nademanee K; Josephson MA; Ikeda N; Venkatesh N; Kannan R Ann N Y Acad Sci; 1984; 432():210-35. PubMed ID: 6395762 [No Abstract] [Full Text] [Related]
14. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749 [TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic and electrophysiologic actions of flecainide in animal models. Kvam DC; Banitt EH; Schmid JR Am J Cardiol; 1984 Feb; 53(5):22B-25B. PubMed ID: 6695815 [TBL] [Abstract][Full Text] [Related]
17. Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure. Dunselman PH; Kingma JH; van Wijk LM; Dijk A; Wesseling H; Lie KI Drugs; 1985; 29 Suppl 4():58-64. PubMed ID: 4006780 [TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias. Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783 [TBL] [Abstract][Full Text] [Related]
19. Oral flecainide acetate for the treatment of ventricular arrhythmias. Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711 [TBL] [Abstract][Full Text] [Related]
20. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Morganroth J; Horowitz LN Am J Cardiol; 1984 Feb; 53(5):89B-94B. PubMed ID: 6695821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]